Copyright
©The Author(s) 2022.
World J Stem Cells. Jul 26, 2022; 14(7): 539-555
Published online Jul 26, 2022. doi: 10.4252/wjsc.v14.i7.539
Published online Jul 26, 2022. doi: 10.4252/wjsc.v14.i7.539
Figure 1 High expression of miR-3682-3p reflected poor prognosis of hepatocellular carcinoma.
A: The expression levels of miR-3682-3p in normal and hepatocellular carcinoma (HCC) tissues in The Cancer Genome Atlas (TCGA) dataset; B: The expression of miR-3682-3p in 34 HCC and paired paracancerous tissue samples as determined by RT-qPCR; C: miR-3682-3p expression in HCC cells (HepG2, Huh7, Hep3B, LM3, and MHCC-97H) and normal liver epithelial (LO2) cells as determined by RT-qPCR; D: Analysis of Kaplan-Meier overall survival curves for HCC patients based on miR-3682-3p expression in TCGA dataset. bP < 0.01, cP < 0.001. Experiments were repeated three times.
- Citation: Chen Q, Yang SB, Zhang YW, Han SY, Jia L, Li B, Zhang Y, Zuo S. miR-3682-3p directly targets FOXO3 and stimulates tumor stemness in hepatocellular carcinoma via a positive feedback loop involving FOXO3/PI3K/AKT/c-Myc. World J Stem Cells 2022; 14(7): 539-555
- URL: https://www.wjgnet.com/1948-0210/full/v14/i7/539.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v14.i7.539